<DOC>
	<DOCNO>NCT02428504</DOCNO>
	<brief_summary>It universal terminally ill patient choose surrogate event disagreement treat physician surrogate end live . There several factor influence terminally ill patient 's decision choose decision maker end / life .</brief_summary>
	<brief_title>Decision Making End Life Individual Preferences</brief_title>
	<detailed_description>The right patient exercise autonomy , whether accept recommendation physician lose patient unable make health relate decision . This basis substitute judgment . Without write advance directive , surrogate assign use relevant state relationship hierarchy , usually family member serf surrogate patient long capacity make medical decision . Several study show surrogate predict patient preference accurately ask respond hypothetical question . Patient designate hierarchy predict patient treatment preference 69 % accuracy whereas legally assign proxy accurate 68 % . Even prior discussion treatment preference seem improve surrogate accuracy . Surrogates make error predict patient 's preference different direction , find several study . Three study find surrogate err provide intervention patient want , others find specific trend . Other study show physician less accurate surrogate predict patient 's wish . Some study show patient want surrogate make decision disagreement patient 's wish surrogate . No study look patient preference conflict surrogate physician . To choose right surrogate paramount . One way analyze patient 's trend 'how ' 'why ' patient choose surrogate . Little known factor influence patient ' decision choose surrogate would decision event disagreement treat physician surrogate . Factors patient 's culture , ethnic religious background may play important role patient ' preference end life . The investigator aim assess terminally ill patient ' decision making preference end life identify specific factor determine preference .</detailed_description>
	<criteria>1 . Nonresectable malignancy undergo palliative care treatment 2 . Severe end stage COPD FEV1 &lt; 30 % receiving home O2 &gt; six month 3 . End stage cardiomyopathy NYHA class III/IV , candidate heart transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Questionnaire</keyword>
</DOC>